USE OF EVIDENCE-BASED PREVENTIVE MEDICAL THERAPIES 1-3 YEARS POST-MYOCARDIAL INFARCTION IN THE PROSPECTIVE GLOBAL TIGRIS REGISTRY

Authors :: D. Brieger
Tabassome Simon
Timothy J Collier
Gunnar Brandrup-Wognsen
Satoshi Yasuda
Stuart J. Pocock
Mauricio G. Cohen
Jose C. Nicolau
Ji Yan Chen
Shaun G. Goodman
Kirsten L. Rennie
Richard Grieve
Karolina Andersson Sundell
Christopher B. Granger
Dirk Westermann
Source :: Journal of the American College of Cardiology. 73:169
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.
Abstract: Global data on use of evidence-based medical (EBM) therapies following myocardial infarction (MI) are rare. Therefore, we investigated regional differences in EBM therapy use and its association with CV death in patients >1 year post MI. The TIGRIS prospective global registry ([NCT01866904][1])

Subjects :: medicine.medical_specialty
Evidence-based practice
business.industry
Internal medicine
education
medicine
In patient
Myocardial infarction
Cardiology and Cardiovascular Medicine
business
medicine.disease
Regional differences
Post myocardial infarction

Full Text Access

Tools